Annual Drug Patent Expirations for JEVTANA+KIT
Jevtana Kit is a drug marketed by Sanofi Aventis Us and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Drug patent litigation for JEVTANA KIT.
This drug has forty-nine patent family members in thirty-two countries.
The generic ingredient in JEVTANA KIT is cabazitaxel. One supplier is listed for this compound. Additional details are available on the cabazitaxel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
